Success Metrics

Clinical Success Rate
66.7%

Based on 6 completed trials

Completion Rate
67%(6/9)
Active Trials
27(53%)
Results Posted
50%(3 trials)
Terminated
3(6%)

Phase Distribution

Ph not_applicable
16
31%
Ph phase_3
5
10%
Ph phase_2
12
24%

Phase Distribution

0

Early Stage

12

Mid Stage

5

Late Stage

Phase Distribution33 total trials
Phase 2Efficacy & side effects
12(36.4%)
Phase 3Large-scale testing
5(15.2%)
N/ANon-phased studies
16(48.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

27

trials recruiting

Total Trials

51

all time

Status Distribution
Active(35)
Completed(6)
Terminated(4)
Other(6)

Detailed Status

Recruiting21
Not yet recruiting8
Completed6
unknown6
Active, not recruiting6
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
51
Active
27
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 212 (36.4%)
Phase 35 (15.2%)
N/A16 (48.5%)

Trials by Status

terminated36%
not_yet_recruiting816%
completed612%
recruiting2141%
unknown612%
withdrawn12%
active_not_recruiting612%

Recent Activity

Clinical Trials (51)

Showing 20 of 51 trialsScroll for more
NCT05840484

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

Recruiting
NCT07749924Not Applicable

Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC

Not Yet Recruiting
NCT07650448Not Applicable

WATER IV PCa (AS Sub-study)

Not Yet Recruiting
NCT06358469Not Applicable

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Recruiting
NCT07669298Not Applicable

Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer

Recruiting
NCT07625527Phase 2

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

Not Yet Recruiting
NCT04558593

Surveillance of Complex Renal Cysts - The SOCRATIC Study

Recruiting
NCT06998342Phase 2

MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer

Recruiting
NCT06974370Phase 2

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

Recruiting
NCT00949819

Active Surveillance for Cancer of the Prostate (ASCaP)

Recruiting
NCT07023432Phase 2

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

Recruiting
NCT07591493Phase 3

Adjuvant Trial in Pancreatic Neuroendocrine Tumors

Not Yet Recruiting
NCT02609685Not Applicable

Active Surveillance of Papillary Thyroid Microcarcinoma

Recruiting
NCT03803553Phase 3

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Recruiting
NCT07547163

Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared

Recruiting
NCT05345847Not Applicable

Steroid Sparing in Immune Related Hepatitis (irH)

Recruiting
NCT05343936

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

Active Not Recruiting
NCT05810467

The Active Surveillance Study

Recruiting
NCT02914873Not Applicable

SPCG17: Prostate Cancer Active Surveillance Trigger Trial

Active Not Recruiting
NCT07262138

Active Surveillance in Older Women With ER+ Breast Cancer

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
51